Bank Of America Corp Curis Inc Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.99 $63,967 - $111,100	-112,223 Reduced 100.0%	4 $0
Q1 2023 May 12, 2023	BUY	$0.51 - $0.78 $20,697 - $31,654	40,583 Added 56.65%	112,227 $67,000
Q4 2022 Feb 10, 2023	SELL	$0.47 - $17.22 $36,736 - $1.35 Million	-78,163 Reduced 52.18%	71,644 $39,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $20,055 - $406,801	-27,102 Reduced 15.32%	149,807 $105,000
Q2 2022 Aug 12, 2022	BUY	$0.71 - $2.43 $97,622 - $334,115	137,496 Added 348.86%	176,909 $173,000
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $595,423 - $1.32 Million	-257,759 Reduced 86.74%	39,413 $94,000
Q4 2021 Feb 08, 2022	BUY	$4.45 - $8.09 $1.17 Million - $2.13 Million	263,678 Added 787.24%	297,172 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $17,266 - $22,018	2,488 Added 8.02%	33,494 $262,000
Q2 2021 Sep 13, 2021	BUY	$7.45 - $16.27 $230,994 - $504,467	31,006 New	31,006 $250,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.